Conversely, in this study in neuroblastoma, we observed in neuroblastoma cells that ATP13A3 knockdown increases sensitivity to DFMO, suggesting that high ATP13A3 expression might drive resistance to DFMO. The gene discussed is ATP13A3; the disease is neuroblastoma.